Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 12-2021 | 06-2021 | 12-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,899,000 | 10,098,000 | 9,722,000 | 13,915,000 | 15,969,000 |
| Marketable Securities | N/A | 1,054,000 | N/A | 900,000 | N/A |
| Receivables | 8,406,000 | 9,787,000 | 7,425,000 | 9,953,000 | 7,203,000 |
| Inventories | 9,366,000 | 8,715,000 | 9,261,000 | 8,352,000 | 8,895,000 |
| Other current assets | 3,975,000 | 384,000 | 3,187,000 | 141,000 | 2,816,000 |
| TOTAL | $28,646,000 | $30,653,000 | $29,595,000 | $33,786,000 | $34,883,000 |
| Non-Current Assets | |||||
| PPE Net | 11,642,000 | 11,976,000 | 10,976,000 | 10,563,000 | 10,604,000 |
| Investments And Advances | 2,644,000 | 2,422,000 | 2,128,000 | 2,105,000 | 2,319,000 |
| Intangibles | 72,533,000 | 69,463,000 | 64,445,000 | 62,785,000 | 62,275,000 |
| Other Non-Current Assets | 6,361,000 | 5,728,000 | 5,177,000 | 5,290,000 | 5,738,000 |
| TOTAL | $93,180,000 | $89,589,000 | $82,726,000 | $80,743,000 | $80,936,000 |
| Total Assets | $121,826,000 | $120,242,000 | $112,321,000 | $114,529,000 | $115,819,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,063,000 | 3,183,000 | 2,225,000 | 2,767,000 | 3,329,000 |
| Accounts payable and accrued liabilities | 6,558,000 | 6,180,000 | 5,374,000 | 5,295,000 | 4,920,000 |
| Other current liabilities | 11,782,000 | 7,328,000 | 10,711,000 | 6,643,000 | 10,311,000 |
| TOTAL | $22,077,000 | $21,295,000 | $19,145,000 | $19,280,000 | $18,808,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,942,000 | 17,123,000 | 17,935,000 | 19,745,000 | 20,404,000 |
| Deferred Revenues | N/A | 319,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 8,599,000 | 8,987,000 | 8,834,000 | 9,510,000 | 10,016,000 |
| TOTAL | $28,445,000 | $29,916,000 | $29,812,000 | $32,102,000 | $33,525,000 |
| Total Liabilities | $50,522,000 | $51,211,000 | $48,957,000 | $51,382,000 | $52,333,000 |
| Shareholders' Equity | |||||
| Common Shares | 2,531,000 | 2,527,000 | 2,522,000 | 2,518,000 | 2,512,000 |
| Other shareholders' equity | 69,034,000 | 66,561,000 | 61,050,000 | 60,826,000 | 60,855,000 |
| TOTAL | $70,951,000 | $68,681,000 | $63,237,000 | $63,001,000 | $63,304,000 |
| Total Liabilities And Equity | $121,473,000 | $119,892,000 | $112,194,000 | $114,383,000 | $115,637,000 |